Ledger.Open graph →
SEC Form D · filed August 15, 2017

Galmed Pharmaceuticals Ltd

Offering
$350K
Sold
$100K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TEL AVIV, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Carol Brosgart · Princeton, NJDirectorChaim Hurvitz · Tel Aviv, L3DirectorWilliam Marth · Tel Aviv, L3DirectorRan Oren · Tel Aviv, L3DirectorTali Gorfine · Tel Aviv, L3ExecCarol Brosgart · Los Angeles, CADirectorDavid Sidransky · Somerset, NJDirectorYohai Stenzler · Tel Aviv, L3ExecLiat Hayardeny · Tel Aviv, L3ExecShmuel Nir · Tel Aviv, L3DirectorAllen Baharaff · Tel Aviv, L3Exec · DirectorChaim Hurvitz · Stratford-upon-Avon, United KingdomDirectorTali Yaron-Eldar · Tel Aviv, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗